Results 1 to 10 of about 46,176 (98)
"Anovlar" as an Oral Contraceptive [PDF]
BMJ, 1962 166 women received the oral contraceptive Anovlar (4 mg norethisterone acetate plus .05 mg ethinyl estradiol) on Cycle Days 5-24 for a total of 1023 cycles. A 100% efficiency rate was encountered. Side effects were few. Nausea occurred in 22% the first cycle and in only 7% by the seventh cycle.
Eleanor Mears, Ellen C. G. Grant
openaire +4 more sources
Triphasic versus monophasic oral contraceptives for contraception [PDF]
Cochrane Database of Systematic Reviews, 2001 Side effects caused by oral contraceptives discourage compliance with, and continuation of, oral contraceptives. Three approaches have been used to decrease these adverse effects: reduction of steroid dose, development of new steroids, and new formulas and schedules of administration.
Vliet, H.A.A.M. van +4 more
openaire +12 more sources
ORAL CONTRACEPTIVES AND HYPERTENSION [PDF]
The Lancet, 1967 Oral contraceptives result in a mild elevation of blood pressure in most women and overt hypertension in about 5%. Both estrogen and progestogen are responsible for the blood pressure effect, but the mechanism is as yet unknown. The risk of cardiovascular complications is found primarily in women over 35 years of age and in those who smoke ...
openaire +4 more sources
ORAL CONTRACEPTIVES AND HEALTH [PDF]
The Lancet, 1974 Dr. Bernal (June 22 p. 1280) states that we have made no adjustment for the bias due to the poorer medical history in the control prior to recruitment. This is incorrect as stated on p. 17 of the report and repeated frequently in relation to the discussions of the findings in particular morbidity categories.
openaire +6 more sources
Oral contraception and health [PDF]
BMJ, 1999 General practice p 96 Oral contraceptives have been studied more intensively than any other medication in history. Yet the recent brouhaha about third generation oral contraceptives and venous thromboembolism is only the latest in a series of “pill scares” over more than three decades.
openaire +3 more sources
Oral contraceptives and cancer [PDF]
Journal of Family Planning and Reproductive Health Care, 2007 Combination-type oral contraceptives (COCs) reduce the risk of endometrial cancer and ovarian cancer, but increase the risk of liver cancer, and may increase the risk of breast cancer and cervical cancer. Analysis of epidemiologic and biologic data on cancers of the breast, endometrium, and ovary suggest that the effects of COCs on cancer rates in ...
openaire +3 more sources
Levetiracetam and Oral Contraceptives
Epilepsy Currents, 2002 Levetiracetam Does Not Alter the Pharmacokinetics of an Oral Contraceptive in Healthy Women Ragueneau-Majlessi I, Levy RH, Janik F Epilepsia 2002;43(7):697–702 Purpose This study was designed to evaluate whether levetiracetam (LEV), a novel antiepileptic drug (AED), influences the pharmacokinetics of steroid oral contraceptives. Methods During a run-
openaire +3 more sources